Objectives The primary objective of this study is to assess the feasibility of preoperative
treatment with atezolizumab combined with preoperative chemoradiation (carboplatin,
paclitaxel and radiation) in terms of completion of treatment with atezolizumab.
Phase:
Phase 2
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)